Our present meta-analysis of 23 case-control studies (10,651 cases and 14,366 controls) provided the most comprehensive analysis of the relationship between the RETN -420C/G polymorphism and the risk of T2DM. This evidence concerns the gene RETN and type 2 diabetes mellitus.